The SUPPORT Research Study
STUDY BASICS
Are you less than 12 weeks pregnant? You may be eligible for a research study to find out if using a trimester-specific prenatal vitamin verses a generic prenatal vitamin starting in the first trimester of pregnancy will improve health. Participants will complete one in-person visit while they are less than 12 weeks of pregnancy. Compensation provided.
STUDY PURPOSE
This research study is being done to find out if using a trimester-specific prenatal vitamin versus a generic prenatal vitamin starting in the first trimester of pregnancy will improve the health of the mother and unborn baby during pregnancy.
COULD THIS STUDY BE RIGHT FOR YOU?
- Are pregnant and 18 years or older
- Are less than 12 weeks pregnant
- Receive care at a Magee-Women’s associated prenatal practice
WHAT PARTICIPANTS CAN EXPECT
You will complete one in-person visit while you are less than 12 weeks of pregnancy.
- Blood samples will be collected
- Brief surveys will be completed
IRB: STUDY25020013B
- Impact of Perelel Trimester-Specific Dietary Supplements vs. Generic Prenatal Supplements on Maternal and Fetal Health Outcomes: A Randomized Controlled Trial (SUPPORT)MEET THE RESEARCHER
Hyagriv Simhan
Hyagriv Simhan, MD, MSCR, is professor at the University of Pittsburgh School of Medicine, and chief of the division of maternal-fetal medicine and medical director of obstetrical services at Magee-Womens Hospital of UPMC. His main area of research has been on preterm birth. Because of his efforts to improve patient safety and quality of care, Dr. Simhan has been awarded the Fine Award from the Pittsburgh Regional Health Initiative, and the Achievement Award for Health Care Quality Improvement/Patient Safety from the Hospital Association of Pennsylvania.
https://pittplusme.org/study/support4control